Evoltra

Evoltra (clofarabine) is an intravenous medication used in cancer treatment. It belongs to a class of drugs known as antimetabolites, which interfere with the growth of cancer cells. This medication is typically administered under medical supervision.

Evoltra is primarily used in the treatment of certain types of cancer, particularly acute lymphoblastic leukemia (ALL) in pediatric patients who have not responded to other treatments. It works by interfering with the DNA synthesis in cancer cells, thereby inhibiting their growth and proliferation. The specific uses of Evoltra are determined by healthcare professionals based on individual patient needs.

Common effects of Evoltra may include fatigue, nausea, and a decreased appetite. Some patients may also experience fever, diarrhea, or an increased risk of infections. These effects can vary widely among individuals and should be discussed with a healthcare provider.

Evoltra should be handled with care and administered only by healthcare professionals. It is important to follow all safety guidelines provided by the manufacturer and healthcare provider. Patients should be monitored regularly for any adverse reactions or changes in their condition.

Evoltra may interact with other medications, including those that suppress the immune system or affect liver function. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain foods may also affect the efficacy of Evoltra.